当前位置: X-MOL 学术Nat. Rev. Drug. Disc. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Joshua Gordon
Nature Reviews Drug Discovery ( IF 122.7 ) Pub Date : 2017-07-31 , DOI: 10.1038/nrd.2017.134


In September 2016, Joshua Gordon joined the NIH as Director of the National Institute of Mental Health (NIMH). For Gordon, who was previously a psychiatrist and neuroscientist at Columbia University Medical Center, this role presented a once-in-a-lifetime opportunity to oversee a US$1.5 billion budget and shape the future of mental health research. When he started, he said his first order of business would be to listen and learn. One year on, he has heard a lot about the institute's classification of mental illnesses for research purposes (known as RDoC), the appropriate balance between basic and clinical research, and the challenges of using genetics to understand psychiatric disease, he told Asher Mullard.

中文翻译:

约书亚·戈登(Joshua Gordon)

2016年9月,约书亚·戈登(Joshua Gordon)加入了美国国立卫生研究院(NIH),担任美国国家心理健康研究所(NIMH)的主任。对于戈登(Gordon)以前是哥伦比亚大学医学中心的精神病学家和神经科学家来说,这个角色提供了千载难逢的机会来监督15亿美元的预算,并塑造心理健康研究的未来。当他开始时,他说他的首要任务是倾听和学习。他告诉Asher Mullard,一年过去了,他听到了很多关于该研究所用于研究目的的精神疾病分类(称为RDoC),基础研究和临床研究之间的适当平衡以及使用遗传学来了解精神病学的挑战的很多信息。
更新日期:2017-08-02
down
wechat
bug